"Designing Growth Strategies is in our DNA"

U.S. Psoriasis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (TNF Inhibitors, Interleukin Inhibitors, and Others), By Type (Plaque Psoriasis, Psoriatic Arthritis, and Others), By Route of Administration (Oral, Parenteral/Systemic, and Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Country Forecast, 2023-2030

Last Updated: December 01, 2025 | Format: PDF | Report ID: FBI108704

 

We will customize the report to meet your research goals, helping you gain a competitive edge, and make informed decisions.

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Psoriasis, 2022
    2. Key Industry Developments
    3. Pipeline Analysis for Key Companies
    4. Impact of COVID-19 on the Market
  5. U.S. Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. TNF Inhibitors
      2. Interleukin Inhibitors
      3. Others
    2. Market Analysis, Insights and Forecast – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral/Systemic
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. AbbVie Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. LEO Pharma A/S
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Amgen Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Eli Lilly and Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Evelo Biosciences, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. UCB S.A.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      11. Boehringer Ingelheim International GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      12. Other Prominent Players
  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Prevalence of Psoriasis, 2022
    2. Key Industry Developments
    3. Pipeline Analysis for Key Companies
    4. Impact of COVID-19 on the Market
  5. U.S. Psoriasis Treatment Market Analysis, Insights and Forecast, 2019-2030
    1. Market Analysis, Insights and Forecast – By Drug Class
      1. TNF Inhibitors
      2. Interleukin Inhibitors
      3. Others
    2. Market Analysis, Insights and Forecast – By Type
      1. Plaque Psoriasis
      2. Psoriatic Arthritis
      3. Others
    3. Market Analysis, Insights and Forecast – By Route of Administration
      1. Oral
      2. Parenteral/Systemic
      3. Topical
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
  6. Competitive Analysis
    1. U.S. Market Share Analysis (2022)
    2. Company Profiles
      1. AbbVie Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      2. Novartis AG
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      3. Johnson & Johnson Services, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      4. Pfizer Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      5. LEO Pharma A/S
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      6. Merck & Co., Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      7. Amgen Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      8. Eli Lilly and Company
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      9. Evelo Biosciences, Inc.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      10. UCB S.A.
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      11. Boehringer Ingelheim International GmbH
        1. Overview
        2. Products
        3. SWOT Analysis
        4. Recent Developments
        5. Strategies
        6. financials (Based on Availability)
      12. Other Prominent Players
Read Less

Figure 1: U.S. Psoriasis Treatment Market Revenue Breakdown (USD billion, %), By Drug Class, 2022 & 2030

Figure 2: U.S. Psoriasis Treatment Market Value Share (%), by Drug Class, 2022 & 2030

Figure 3: U.S. Psoriasis Treatment Market Value Share (%), by Type, 2022 & 2030

Figure 4: U.S. Psoriasis Treatment Market Value Share (%), by Route of Administration, 2022 & 2030

Figure 5: U.S. Psoriasis Treatment Market Value Share (%), by Distribution Channel, 2022 & 2030

Figure 6: U.S. Psoriasis Treatment Market Share (%), By Company, 2022

Table 1: U.S. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2019–2030

Table 2: U.S. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Type, 2019–2030

Table 3: U.S. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Route of Administration, 2019–2030

Table 4: U.S. Psoriasis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2019–2030

U.S. Psoriasis Treatment Market
  • 2019-2029
  • 2022
  • 2019-2021
  • 95
Download Free Sample

    man icon
    Mail icon
    Captcha refresh
Growth Advisory Services
    How can we help you uncover new opportunities and scale faster?
Clients
3M
Toshiba
Fresenius
Johnson
Siemens
Abbot
Allergan
American Medical Association
Becton, Dickinson and Company
Bristol-Myers Squibb Company
Henry Schein
Mckesson
Mindray
National Institutes of Health (NIH)
Nihon Kohden
Olympus
Quest Diagnostics
Sanofi
Smith & Nephew
Straumann

Related Reports